JPMorgan Chase & Co. set a €60.00 ($69.77) price target on Lanxess (ETR:LXS) in a research report sent to investors on Friday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock.
LXS has been the subject of a number of other research reports. Deutsche Bank set a €70.00 ($81.40) target price on Lanxess and gave the company a buy rating in a report on Friday, July 19th. Morgan Stanley set a €54.00 ($62.79) target price on Lanxess and gave the company a neutral rating in a report on Monday, July 15th. DZ Bank restated a neutral rating on shares of Lanxess in a report on Friday, June 14th. Warburg Research set a €67.00 ($77.91) target price on Lanxess and gave the company a buy rating in a report on Tuesday, May 14th. Finally, Baader Bank set a €45.00 ($52.33) target price on Lanxess and gave the company a sell rating in a report on Friday. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and eight have assigned a buy rating to the company. Lanxess currently has an average rating of Hold and a consensus target price of €60.61 ($70.48).
LXS opened at €49.31 ($57.34) on Friday. The firm has a fifty day simple moving average of €52.72. The stock has a market capitalization of $4.51 billion and a price-to-earnings ratio of 10.74. Lanxess has a 12-month low of €39.47 ($45.90) and a 12-month high of €72.42 ($84.21). The company has a debt-to-equity ratio of 101.71, a current ratio of 2.61 and a quick ratio of 1.53.
LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.
Further Reading: Leveraged Buyout (LBO) Explained
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.